This trial will study how disrupted communication between the thalamus and cortex affects sleep, attention, and sensory sensitivities in children with autism. Sleep spindles provide a noninvasive way to assess this. Melatonin's effect on sleep spindles will also be examined.
1 Primary · 1 Secondary · Reporting Duration: Five nights of sleep over two weeks
Side Effects for
1 Treatment Group
1 of 1
30 Total Participants · 1 Treatment Group
Primary Treatment: Melatonin · No Placebo Group · N/A
Who is running the clinical trial?
Age 12 - 18 · All Participants · 4 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is the research program open to elderly individuals aged 85 and over?
"This trial seeks to enrol participants aged between 12 and 18. There are 225 trials available for people below the age of majority, while 42 exist specifically for those over 65 years old." - Anonymous Online Contributor
Is this research study presently recruiting participants?
"Yes, the information hosted on clinicaltrials.gov attests to this trial's active recruitment process which began January 1st 2023 and was last updated February 7th 2023. The study is searching for 30 participants in one medical centre." - Anonymous Online Contributor
Am I an appropriate candidate for this research endeavor?
"30 male and female patients with a diagnosis of Autism Spectrum Disorder between the ages 12-18, who can comprehend and reply to English language questionnaires will be admitted into this trial." - Anonymous Online Contributor
What is the overall cohort size of participants involved in this research endeavor?
"Affirmative. Clinicaltrials.gov confirms that this clinical trial, which was first announced on January 1st 2023, is actively recruiting participants. 30 patients need to be gathered from a single medical site." - Anonymous Online Contributor